Martin Pulé
Founder presso AUTOLUS THERAPEUTICS PLC
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Martin Pulé is the founder of Autolus Therapeutics Plc, where he currently holds the title of Chief Scientific Officer & Senior Vice President.
Autolus Therapeutics Plc was founded in 2014.
Dr. Pulé is also the founder of Autolus Ltd.
Dr. Pulé's education history includes an undergraduate degree from University College Dublin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
0.42% | 01/03/2023 | 698 741 ( 0.42% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Martin Pulé
| Società | Posizione | Inizio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Founder | 01/09/2014 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Founder | - |
Formazione di Martin Pulé
| University College Dublin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Martin Pulé
